| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001094312A3 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | WO2001082918A9 Method for the prevention of apoptosis |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 08/08/2002 | WO2001080895A3 Methods and compositions for the treatment of cardiac indications |
| 08/08/2002 | WO2001077376A3 Diagnosis of diseases associated with metastasis |
| 08/08/2002 | WO2001076451A9 Diagnosis of diseases associated with metabolism |
| 08/08/2002 | WO2001070211A3 L-arginine and phosphodiesterase (pde) inhibitor synergism |
| 08/08/2002 | WO2001051641A9 Irak-4: compositions and methods of use |
| 08/08/2002 | WO2001051523A3 Anti-angiogenic proteins and fragments and methods of use thereof |
| 08/08/2002 | WO2001016330A3 Prevention of affections associated with porcine circovirus-2 |
| 08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 08/08/2002 | US20020107390 Thyromimetic organic compounds |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107289 Regulation of phospholipase D activity |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes). |
| 08/08/2002 | US20020107254 P-substituted-N-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-N-pyridin-2-yl-benzamide, |
| 08/08/2002 | US20020107250 Orally deliverable cyclooxygenase-2 inhibitor of low water solubility, for example celecoxib, and a glycol ether, for example diethylene glycol monoethyl ether. |
| 08/08/2002 | US20020107247 Method of treating sexual disturbances |
| 08/08/2002 | US20020107243 Nitro-benzamides useful as Anti-arrhythmic agents |
| 08/08/2002 | US20020107240 N-substituted glycine derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 08/08/2002 | US20020107236 Methods of treating sexual dysfunction associated with hypertension |
| 08/08/2002 | US20020107230 Methods and formulations for the treatment of female sexual dysfunction |
| 08/08/2002 | US20020107206 Treatment of acute coronary syndrome with GLP-1 |
| 08/08/2002 | US20020107197 Ligands for G protein coupled receptors and methods of using them |
| 08/08/2002 | US20020107178 Methods and preparations for curing clinically ill patients |
| 08/08/2002 | US20020107177 And methods for identifying Factor XIIIa inhibitors by contacting chemical in question with lipoprotein(a) component, a matrix component, and Factor XIIIa; complex formation inhibition indicates activity |
| 08/08/2002 | US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 08/08/2002 | US20020106732 Smad6 and uses thereof |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106630 Method of identifying HIBEF51 receptor inhibitors |
| 08/08/2002 | US20020106369 Method of inhibiting stenosis and restenosis |
| 08/08/2002 | CA2438594A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | CA2437021A1 Adiponectin-associated protein |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk) |
| 08/08/2002 | CA2436556A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
| 08/08/2002 | CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436539A1 Ethanolates of sodium-hydrogen exchanger type-1 inhibitor |
| 08/08/2002 | CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436429A1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | CA2436425A1 Hypoglycemic agent |
| 08/08/2002 | CA2436397A1 Method of treating certain eye diseases |
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2436209A1 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | CA2436133A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | CA2436130A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | CA2434970A1 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2434495A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2434491A1 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | CA2434281A1 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | CA2433553A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
| 08/08/2002 | CA2433351A1 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 08/08/2002 | CA2432997A1 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | CA2431559A1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | CA2430878A1 Anticholesterolemic edible oil |
| 08/08/2002 | CA2429969A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | CA2426582A1 Gene delivery formulations and methods for treatment of ischemic conditions |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1229024A1 m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRIN ALPHA-V BETA-3 ANTAGONISM |
| 08/07/2002 | EP1229010A1 Novel diarylamide derivatives and use thereof as medicines |
| 08/07/2002 | EP1228768A1 Medicament for the protection against thrombotic diseases |
| 08/07/2002 | EP1228765A1 Cholesterol lowering agent |
| 08/07/2002 | EP1228367A2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228221A2 Human sphingosine kinase gene |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1228080A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 08/07/2002 | EP1228072A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 08/07/2002 | EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228059A1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228058A1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 08/07/2002 | EP1228055A1 Dihydroaminobenzo[b]- and [c]furans as retinoid-like agents |
| 08/07/2002 | EP1228054A1 Compounds and their use as cysteine protease inhibitors |
| 08/07/2002 | EP1228053A1 Substituted piperazine derivatives, the production and use thereof as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 08/07/2002 | EP1228047A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |